Submitted by Nicola-Swanborough on Wed, 14/09/2016 - 12:01
The epilepsy drug Trobalt, also known as retigabine, is to be discontinued and will no longer be available after June 2017.
Submitted by olivia-rzadkiewicz on Thu, 31/03/2016 - 16:27
Researchers have designed a more effective version of retigabine, a drug used to treat epilepsy, offering the potential for fewer side effects.
Submitted by olivia-rzadkiewicz on Thu, 04/02/2016 - 16:05
Two separate studies have analysed the benefits and side-effects of two antiepileptic drugs, rufinamide and retigabine.